- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01918293
Self-Management Using Smartphone Application for Chronic Disease Care in Real siTuation (SMART-Asthma): Adult
November 26, 2013 updated by: Jongha Park, Inje University
Self-Management Using Smartphone Application for Chronic Disease Care in Real siTuation (SMART-Asthma) in Adult
Bronchial asthma is an chronic airway disease with bronchial hypersensitivity due to inflammation and bronchial muscle contraction.
It can cause recurrent dyspnea, cough, wheezing and severe life-threatening attack and lower quality of life.
In addition, it make large amount of socioeconomic loss as about 3.7 billion US dollars.
Study Overview
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Busan, Korea, Republic of, 612-896
- Haeundae Paik Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- using smartphone
- alleged bronchial asthma over 3months & positive of bronchodilator response test or bronchial provocation test
Exclusion Criteria:
- COPD
- active pulmonary TUBERCULOSIS
- Acute exacerbation within 4weeks
- severe psychological disorder
- severe systemic disease; severe LC, ESRD ...
- MALIGNANCY
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SMART arm
Using smartphone application for control of asthma
|
The smartphone application for self-management of Asthma offers symptom diary, general information for asthma, the information of asthma drugs,the guideline for inhaler and the specific action plan according to daily symptom and FEV1.
Other Names:
|
|
No Intervention: conventional arm
non-using smartphone application for control asthma
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The efficacy of smartphone application for asthma control test (ACT)and quality of life
Time Frame: at least 2 times a week
|
Using ACT and ALQL score (QoL), we will investigate the efficacy of smanrtphone application for control of asthma compared to smartphone app.
using group and smartphone app.
non-using group
|
at least 2 times a week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
FEV1 (Forced expiratory volume in 1 second ) and FVC (Forced vital capacity)
Time Frame: at least 1 time a month
|
Using spirometer to check the variation of FEV1,we will investigate the efficacy of smanrtphone application for control of asthma compared to smartphone app.
using group and smartphone app.
non-using group
|
at least 1 time a month
|
|
Acute exacerbation of bronchial asthma
Time Frame: at least 1 time a week
|
Using medical record and questionaire of acute exacerbation,we will investigate the efficacy of smanrtphone application for control of asthma compared to smartphone app.
using group and smartphone app.
non-using group
|
at least 1 time a week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
October 1, 2013
Study Registration Dates
First Submitted
August 6, 2013
First Submitted That Met QC Criteria
August 6, 2013
First Posted (Estimate)
August 7, 2013
Study Record Updates
Last Update Posted (Estimate)
November 27, 2013
Last Update Submitted That Met QC Criteria
November 26, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SMART-ASTHMA (ADULT)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on BRONCHIAL ASTHMA
-
Vanderbilt University Medical CenterWithdrawnAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
Johann Wolfgang Goethe University HospitalCompleted
-
AstraZenecaActive, not recruitingBronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy)Japan
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingSevere Asthma | Asthma Exacerbations | Bronchial ThermoplastyNetherlands
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
SamA Pharmaceutical Co., LtdCompleted
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedAsthma, Bronchial | Bronchial AsthmaRussian Federation, Poland, Germany, Ukraine, Czech Republic
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedAsthma, Bronchial | Bronchial AsthmaRussian Federation, Hungary, Germany, Poland, Bulgaria, Ukraine, Czech Republic
-
Value Outcomes Ltd.AstraZenecaCompletedAsthma, Bronchial | Bronchial Asthma | Asthma Chronic | Asthma; EosinophilicCzechia
-
Johann Wolfgang Goethe University HospitalWithdrawnAllergy | Allergic Asthma | Intrinsic Asthma | Bronchial HyperresponsivenessGermany
Clinical Trials on SMART ARM
-
Inje UniversityUnknownBOWEL PREPARATION (BOWEL CLEANSING)Korea, Republic of
-
University of Alabama at BirminghamCompleted
-
The University of Hong KongCompletedMild Cognitive ImpairmentHong Kong
-
Medtronic - MITGInstitute for Skin Research, IsraelCompleted
-
Indiana UniversityRecruiting
-
Medical University of South CarolinaBoston Scientific CorporationRecruitingSubcutaneous ICD | Myopotential InterferenceUnited States
-
Massachusetts General HospitalElizabeth Dole FoundationCompleted
-
University of Illinois at Urbana-ChampaignCompleted
-
Pathway Medtech, LLC.Haku TechnologyRecruitingSleep Apnea | Sleep Quality | Sleep-disordered Breathing (SDB)Belgium
-
University of California, San FranciscoSan Francisco Veterans Affairs Medical CenterCompletedPost Traumatic Stress DisorderUnited States